It has been demonstrated that it acts as a positive regulator of antiapoptotic Stat3/IL-6 receptor signaling by directly suppressing SOCS-1, thereby facilitating malignant growth of multiple myeloma [63]. This evidence concerns the gene SOCS1 and plasma cell myeloma.